ATE405572T1 - Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese - Google Patents
Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen syntheseInfo
- Publication number
- ATE405572T1 ATE405572T1 AT05718265T AT05718265T ATE405572T1 AT E405572 T1 ATE405572 T1 AT E405572T1 AT 05718265 T AT05718265 T AT 05718265T AT 05718265 T AT05718265 T AT 05718265T AT E405572 T1 ATE405572 T1 AT E405572T1
- Authority
- AT
- Austria
- Prior art keywords
- chirogenic
- phospholanes
- asymmetric synthesis
- production
- disclosed
- Prior art date
Links
- 150000004850 phospholanes Chemical class 0.000 title abstract 3
- 238000011914 asymmetric synthesis Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- GWLJTAJEHRYMCA-UHFFFAOYSA-N phospholane Chemical class C1CCPC1 GWLJTAJEHRYMCA-UHFFFAOYSA-N 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 1
- 150000005829 chemical entities Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- 229910052703 rhodium Inorganic materials 0.000 abstract 1
- 239000010948 rhodium Substances 0.000 abstract 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 230000000707 stereoselective effect Effects 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
- C07F9/65685—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine oxide or thioxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
- C07F9/65683—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55904304P | 2004-04-01 | 2004-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE405572T1 true ATE405572T1 (de) | 2008-09-15 |
Family
ID=34962295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05718265T ATE405572T1 (de) | 2004-04-01 | 2005-03-23 | Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7390931B2 (de) |
| EP (1) | EP1735324B1 (de) |
| JP (1) | JP2007530657A (de) |
| AT (1) | ATE405572T1 (de) |
| BR (1) | BRPI0508998A (de) |
| CA (1) | CA2561755A1 (de) |
| DE (1) | DE602005009161D1 (de) |
| ES (1) | ES2309731T3 (de) |
| WO (1) | WO2005095424A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0934061B3 (de) | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba und dessen derivate zur schmerzbehandlung |
| CN101160281A (zh) * | 2005-04-06 | 2008-04-09 | 特瓦制药工业有限公司 | 结晶形态的普瑞巴林 |
| US7488846B2 (en) * | 2005-04-11 | 2009-02-10 | Teva Pharmaceuical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
| MX2007012606A (es) * | 2005-04-11 | 2008-01-11 | Teva Pharma | Proceso para elaborar (s)-pregabalina. |
| ES2372700T3 (es) * | 2005-05-10 | 2012-01-25 | Teva Pharmaceutical Industries Ltd | Resolución óptica del ácido 3-carbamoilmetil-5-metil hexanoico. |
| WO2006122258A1 (en) * | 2005-05-10 | 2006-11-16 | Teva Pharmaceutical Industries Ltd. | Method for the preparation of pregabalin and salts thereof |
| MX2007000525A (es) | 2005-05-10 | 2007-03-28 | Teva Pharma | Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella. |
| WO2007035789A1 (en) * | 2005-09-19 | 2007-03-29 | Teva Pharmaceutical Industries Ltd. | Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin |
| WO2007127309A2 (en) * | 2006-04-24 | 2007-11-08 | Teva Pharmaceutical Industries Ltd. | Processes for the synthesis of 3-isobutylglutaric acid |
| WO2007139933A2 (en) * | 2006-05-24 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
| WO2007143113A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | The use of enzymatic resolution for the preparation of intermediates of pregabalin |
| WO2007143152A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | Preparation of (s)-pregabalin-nitrile |
| TW200846308A (en) * | 2007-03-22 | 2008-12-01 | Teva Pharma | Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid |
| WO2009046309A2 (en) * | 2007-10-03 | 2009-04-09 | Teva Pharmaceutical Industries Ltd. | Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| WO2009158343A1 (en) * | 2008-06-23 | 2009-12-30 | Teva Pharmaceutical Industries, Ltd. | Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester |
| CN103788133A (zh) * | 2014-01-22 | 2014-05-14 | 常州大学 | 一种含磷五元杂环类化合物及其合成方法 |
| CN109776486A (zh) * | 2019-02-26 | 2019-05-21 | 武汉松石科技股份有限公司 | 一种硫酸亚丙酯的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| EP0934061B3 (de) * | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba und dessen derivate zur schmerzbehandlung |
| US6329429B1 (en) * | 1997-06-25 | 2001-12-11 | Warner-Lambert Company | Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases |
| US6194459B1 (en) * | 1997-08-19 | 2001-02-27 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants |
| AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
| US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
| BR9911887A (pt) * | 1998-07-09 | 2001-03-27 | Warner Lambert Co | Método para o tratamento da insÈnia |
| PL345340A1 (en) * | 1998-07-09 | 2001-12-17 | Warner Lambert Co | Compositions comprising gaba analogs and caffeine |
| WO2000023067A1 (en) * | 1998-10-16 | 2000-04-27 | Warner-Lambert Company | Method for the treatment of mania and bipolar disorder |
| ATE291028T1 (de) * | 2000-12-13 | 2005-04-15 | Warner Lambert Co | P-chirale bisphospholane ligande, deren übergangsmetall-komplexe |
-
2005
- 2005-03-23 DE DE602005009161T patent/DE602005009161D1/de not_active Expired - Fee Related
- 2005-03-23 AT AT05718265T patent/ATE405572T1/de not_active IP Right Cessation
- 2005-03-23 BR BRPI0508998-0A patent/BRPI0508998A/pt not_active IP Right Cessation
- 2005-03-23 WO PCT/IB2005/000768 patent/WO2005095424A1/en not_active Ceased
- 2005-03-23 CA CA002561755A patent/CA2561755A1/en not_active Abandoned
- 2005-03-23 ES ES05718265T patent/ES2309731T3/es not_active Expired - Lifetime
- 2005-03-23 JP JP2007505651A patent/JP2007530657A/ja not_active Withdrawn
- 2005-03-23 EP EP05718265A patent/EP1735324B1/de not_active Expired - Lifetime
- 2005-03-31 US US11/095,044 patent/US7390931B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050222464A1 (en) | 2005-10-06 |
| DE602005009161D1 (de) | 2008-10-02 |
| EP1735324A1 (de) | 2006-12-27 |
| WO2005095424A1 (en) | 2005-10-13 |
| ES2309731T3 (es) | 2008-12-16 |
| CA2561755A1 (en) | 2005-10-13 |
| EP1735324B1 (de) | 2008-08-20 |
| US7390931B2 (en) | 2008-06-24 |
| WO2005095424A8 (en) | 2005-12-15 |
| BRPI0508998A (pt) | 2007-09-04 |
| JP2007530657A (ja) | 2007-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005009161D1 (de) | Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese | |
| Bezzenine-Lafollée et al. | First-row late transition metals for catalytic alkene hydrofunctionalisation: recent advances in CN, CO and CP bond formation | |
| MXPA05012362A (es) | Yodopirazolilcarboxanilidas. | |
| DE60323340D1 (de) | Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle | |
| ATE438633T1 (de) | Benzo (d) isoxazol-3-yl-amin- verbindungen und deren verwendung als vanilloid-rezeptor liganden | |
| DE50306845D1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
| ATE370956T1 (de) | Metallorganisches gerüstmaterial, herstellung und verwendung | |
| DE60330789D1 (de) | Nickelsubstituierte und gemischt nickel- und cobaltsubstituierte chromoxidzusammensetzungen, deren herstellung und deren verwendung als katalysatoren und katalysatorvorläufer | |
| DE502008001144D1 (de) | Verfahren zur einstufigen herstellung von 2-methyltetrahydrofuran aus furfural an zwei katalysatoren in strukturierter schüttung | |
| DK1325013T3 (da) | Katalysator til asymmetrisk (overförsels) hydrogerering | |
| MX2009007436A (es) | Derivados espirociclicos de acido tetronico. | |
| Cadierno | Synthetic applications of the Parkins nitrile hydration catalyst [PtH {(PMe2O) 2H}(PMe2OH)]: A review | |
| DE50306111D1 (de) | Hydroxydiphosphine und deren verwendung in der katalyse | |
| MXPA06002349A (es) | Derivados de aminopropanol. | |
| ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
| WO2006024389A3 (de) | Biphenylthiazolcarboxamide | |
| ATE486841T1 (de) | Verfahren zur herstellung von pregabalin und salzen daraus | |
| ATE515198T1 (de) | Zusammensetzung für die enterale verabreichung von mikroorganismen | |
| ATE409695T1 (de) | Furancarboxamide | |
| WO2006024387A3 (de) | Biphenylthiazolcarboxamide | |
| WO2006091924A3 (en) | Producing carotenoids | |
| DE602006004911D1 (de) | Gasphasenoxidationskatalysator und dessen Verwendung zur Herstellung von Acrylsäure | |
| ATE442355T1 (de) | Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung | |
| WO2007115929A8 (de) | Thiazolyl-dihydro-quinazoline | |
| DE50306803D1 (de) | Neue nickel-, palladium- und platin-carbenkomplexe, ihre herstellung und verwendung in katalytischen reaktionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |